|
FY2025
12 months to Dec 31, 2025
|
FY2024
10 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Payment of formation costs through issuance of founder shares | ||
| Payment of formation costs through promissory note | ||
| Payment of operation costs through promissory note | ||
| Interest earned on marketable securities held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash into Trust Account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Proceeds from sale of Private Placement Units | ||
| Proceeds from advances from Sponsor | ||
| Proceeds from sale of founder shares | ||
| Proceeds from promissory note - related party | ||
| Repayment of promissory note - related party | ||
| Payment of offering costs | ||
| Net cash provided (used in) by financing activities | ||
| Net Change in Cash and Cash Equivalents | ||
| Cash and cash equivalents – Beginning of period | ||
| Cash and cash equivalents – End of period | ||
| Supplemental disclosure of cash flow information: | ||
| Offering costs included in accrued offering costs | ||
| Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | ||
| Deferred offering costs paid through promissory note – related party |
Loading...
